ctrl K

Coya Therapeutics Inc. (COYA)

NASDAQ: COYA · Real-Time Price · USD

6.33

0.05 (0.80%)

At close: May 02, 2025, 3:59 PM

6.63

4.69%

After-hours: May 02, 2025, 05:25 PM EDT

Coya Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	3.55M	6M	n/a	n/a	n/a
Cost of Revenue	27.36K	27.36K	27.36K	16.13K	n/a
Gross Profit	3.53M	5.97M	-27.36K	-16.13K	n/a
Operating Income	-17.22M	-7.9M	-9.81M	-4.87M	-694.77K
Interest Income	n/a	n/a	n/a	n/a	58.46
Pretax Income	-15.6M	-7.26M	-12.24M	-4.89M	-733.2K
Net Income	-14.88M	-7.99M	-14.68M	-4.87M	-733.2K
Selling & General & Admin	8.89M	7.83M	4.85M	2.31M	445.8K
Research & Development	11.87M	6.04M	4.94M	2.54M	248.97K
Other Expenses	n/a	n/a	27.36K	16.13K	n/a
Operating Expenses	20.75M	13.91M	9.81M	4.87M	694.77K
Interest Expense	n/a	n/a	2.43M	n/a	38.98K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	445.13K
Cost & Expenses	20.8M	13.91M	9.81M	4.87M	694.77K
Income Tax Expense	-720.29K	723.85K	2.43M	-21.48K	-704.65
Shares Outstanding (Basic)	15.24M	10.16M	9.95M	9.68M	9.68M
Shares Outstanding (Diluted)	15.24M	10.16M	9.95M	9.68M	9.68M
EPS (Basic)	-0.98	-0.79	-1.48	-0.5	-0.08
EPS (Diluted)	-0.98	-0.79	-1.48	-0.5	-0.08
EBITDA	-15.57M	-7.88M	-12.22M	-4.85M	10.44K
EBIT	-17.25M	-7.9M	-12.24M	-4.89M	-694.22K
Depreciation & Amortization	27.36K	27.36K	27.36K	16.13K	704.65K